Clinical Trial Update: A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

This document provides a status update on a Phase II study evaluating UFUR (tegafur/uracil) plus thalidomide for advanced or metastatic hepatocellular carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Thalidomide (thalidomide)
• UFUR (tegafur/uracil)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: UNKNOWN